蒙特卢卡斯特的脏保护潜力:一个范围审查
Roham Sarmadian1, Abolfazl Gilani2, Saba Mehrtabar3
1Infectious Disease Research Center.
Annals of medicine and surgery (2012)
|June 7, 2024
概括
蒙特卢卡斯特通过减少炎症和氧化压力来保护脏免受损伤. 本综述强调了其对急性损伤和其他病的潜在益处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 损伤是由各种因素引起的,导致结构和功能障碍.
- 急性损伤 (AKI) 表示功能迅速下降,而慢性病则涉及几个月的逐渐恶化.
- 损伤机制包括受损的微循环,炎症和氧化应激,其中cysteinyl-leukotrienes (CysLTs) 作为关键的炎症媒介.
研究的目的:
- 对蒙特卢卡斯特对脏疾病的影响进行范围审查.
- 在实验和人体研究中评估蒙特卢卡斯特的脏保护作用.
主要方法:
- 使用PubMed,Scopus和Web of Science数据库进行范围审查方法.
- 包括2022年之前发表的研究,包括质量评估和数据提取.
- 根据相关性和影响的预定义纳入标准对数据进行分析.
主要成果:
- 包括来自8个国家的30项研究,证明了蒙特卢卡斯特的治疗效果.
- 蒙特卢卡斯特在各种毒性和AKI实验模型中显示出有效性,包括因西斯,阿米卡辛和辐射引起的模型.
- 在患有性综合征,肺炎和其他病的人群中报告了积极的结果,这些结果归因于蒙特卢卡斯特的抗炎,抗氧化和抗丧性质.
结论:
- 蒙特卢卡斯特作为保护剂具有显著的潜力,特别是在早期损伤中.
- 它的治疗效益来自于减轻炎症,氧化应激和中性粒细胞透.
- 需要进一步的临床研究来充分阐明蒙特卢卡斯特的脏保护机制和应用.
更多相关视频
12:04Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
13.8K
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
17.5K
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271
01:25Antihypertensive Drugs: Direct Renin Inhibitors
585
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
585
01:17Drugs Used in Lower Respiratory Disorders: Overview
420
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
420
01:17Factors Affecting Renal Clearance: Renal Impairment
84
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
84